Irisin, a novel polypeptide hormone proteolytically processed from fibronectin type III domain-containing protein 5 (FNDC5), protects against cardiac hypertrophy and improves chronic pressure overload-impaired autophagy flux via the activation of AMPK signaling [41]. The gene discussed is FNDC5; the disease is cardiac hypertrophy.